Developing therapies to treat mitochondrial dysfunction.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | STEALTH BIOTHERAPEUTICS INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$120,000 | |
| 2026 | STEALTH BIOTHERAPEUTICS INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$120,000 | |
| 2025 | STEALTH BIOTHERAPEUTICS INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$110,000 | |
| 2025 | STEALTH BIOTHERAPEUTICS INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$110,000 | |
| 2025 | STEALTH BIOTHERAPEUTICS INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$110,000 | |
| 2025 | STEALTH BIOTHERAPEUTICS INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | |
| 2024 | STEALTH BIOTHERAPEUTICS INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$40,000 | |
| 2024 | STEALTH BIOTHERAPEUTICS INC. |
3rd Quarter (July 1 - Sep 30) AMENDED |
$40,000 | |
| 2024 | STEALTH BIOTHERAPEUTICS INC. |
3rd Quarter (July 1 - Sep 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| STEALTH BIOTHERAPEUTICS INC. | 9 | $700,000 |
| Issue | Activities |
|---|---|
| Health Issues | 9 |